ciprofloxacin has been researched along with palmitic acid in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (75.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Kamal, N; Shafer, WM | 1 |
Bucar, F; Gröblacher, B; Kunert, O | 1 |
Carballeira, NM; Gutierrez, R; Montano, N; Ortíz-Soto, G; Ríos-Olivares, E; Rivera-Torres, Y; Rodríguez, JW; Rosario, J; Sanabria-Ríos, DJ; Torres-García, Y | 1 |
Bielenica, A; Chrzanowska, A; Olejarz, W; Roszkowski, P; Stępień, K; Struga, M | 1 |
4 other study(ies) available for ciprofloxacin and palmitic acid
Article | Year |
---|---|
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Escherichia coli Proteins; Genetic Complementation Test; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis | 2010 |
Compounds of Alpinia katsumadai as potential efflux inhibitors in Mycobacterium smegmatis.
Topics: Alpinia; Antibiotics, Antitubercular; Antitubercular Agents; Diarylheptanoids; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium smegmatis; Plant Extracts; Seeds | 2012 |
Chemical conjugation of 2-hexadecynoic acid to C5-curcumin enhances its antibacterial activity against multi-drug resistant bacteria.
Topics: Alkynes; Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Curcumin; DNA Gyrase; DNA, Superhelical; Escherichia coli; Fatty Acids, Unsaturated; Humans; Leukocytes, Mononuclear; Methicillin-Resistant Staphylococcus aureus; Staphylococcus aureus; Topoisomerase II Inhibitors; Vero Cells | 2015 |
Anticancer and antimicrobial effects of novel ciprofloxacin fatty acids conjugates.
Topics: Antineoplastic Agents; Cell Death; Cell Proliferation; Cell Survival; Cells, Cultured; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Fatty Acids; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Molecular Structure; Structure-Activity Relationship | 2020 |